Yayınlar & Eserler

Yayın Ağı
Makaleler 155
Tümü (155)
SCI-E, SSCI, AHCI (96)
SCI-E, SSCI, AHCI, ESCI (124)
ESCI (27)
Scopus (113)
TRDizin (38)
Diğer Yayınlar (18)

1. Development of a behavioural theory-based New Medicine Service toolkit for community pharmacists to promote medication adherence

OKUYAN B., AY N. P., SANCAR M., Ozcan V., Durak-Albayrak O., Turker M., et al.
International Journal of Clinical Pharmacy , cilt.47, sa.6, ss.1794-1811, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Dentists’ knowledge, attitudes, and practices regarding antithrombotic drugs: pre-post test study

Yürük F. U., Tezcan S., Cengiz A., Sancar M.
BMC Medical Education , cilt.25, sa.1, 2025 (SCI-Expanded) Creative Commons License identifier identifier

3. Evaluation of the clinical pharmacist’s effect on achieving treatment goals in patients with hypothyroidism: a randomized controlled trial

Ayhan Y. E., BEKTAY M. Y., YAVUZ D., SANCAR M.
BMC Endocrine Disorders , cilt.25, sa.1, 2025 (SCI-Expanded) identifier identifier

4. Psychometric evaluation of a Theoretical Domains Framework based questionnaire on community pharmacists’ pharmaceutical care service for breastfeeding women

Ucar Yaman N., AY N. P., SANCAR M., Büyükkayhan D., OKUYAN B.
International Journal of Clinical Pharmacy , cilt.47, sa.5, ss.1232-1238, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence

Goncuoglu C., KARA E., Ceylan C., AY N. P., SANCAR M., OKUYAN B.
British Journal of Clinical Pharmacology , cilt.91, sa.9, ss.2590-2597, 2025 (SCI-Expanded) identifier identifier

6. Clinical Pharmacist’s Input in Identification and Resolution of Drug-Related Problems in the Neonatal and Pediatric Intensive Care Units

Ay Z. Y., Bayraktar S., SANCAR M., Büyükkayhan D., Apikoglu S.
Clinical and Experimental Health Sciences , cilt.15, sa.2, ss.316-323, 2025 (ESCI) identifier

7. Introduction to accreditation in pharmacy education in Türkiye: Association for evaluation and accreditation of pharmacy education programs

Apikoglu S., SANCAR M., KİRBECİ S., Eke B., Burgaz S., Kır S., et al.
Istanbul Journal of Pharmacy , cilt.55, sa.1, ss.39-48, 2025 (Hakemli Dergi) identifier

8. Patient-Oriented pharmacy education

SANCAR M.
Istanbul Journal of Pharmacy , cilt.55, sa.1, ss.49-54, 2025 (Hakemli Dergi) identifier

9. Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study

Kingir Baycar Z. B., SANCAR M., AY N. P., Demirtunc R., Nuhoglu C., Misirli C. H., et al.
International Journal of Clinical Pharmacy , cilt.47, sa.1, ss.187-195, 2025 (SCI-Expanded, Scopus) identifier identifier

10. Evaluation of the Effect of Management of Drug-Related Problems on Clinical Outcomes of Pulmonary Embolism Outpatients: A Randomized Controlled Trial

Ayhan Y. E., Aksoy M., Abdulrahman Y., Şahin Eröksüz Z. S., Vezir D., Mercümek B., et al.
Journal of Clinical Medicine , cilt.14, sa.4, 2025 (SCI-Expanded) identifier identifier

11. The effect of clinical pharmacist-led pharmaceutical care services on medication adherence, clinical outcomes and quality of life in patients with stroke: a randomised controlled trial

Cengiz K. N., MİDİ İ., SANCAR M.
International Journal of Clinical Pharmacy , cilt.47, sa.1, ss.99-106, 2025 (SCI-Expanded) identifier identifier

12. Anti-Microbial Dose Adjustment in Critically Ill Patients with Acute Kidney Injury: Traditional Review

ÖZGAN B., AYHAN Y. E., SANCAR M.
Journal of Literature Pharmacy Sciences , cilt.14, sa.1, ss.35-44, 2025 (Hakemli Dergi)

13. Clinical Course of Amantadine in Patients with Prolonged Consciousness Disorder in the Intensive Care Unit

AYHAN Y. E., ÖZGAN B., KARAKURT S., SANCAR M.
Istanbul Journal of Pharmacy , 2025 (ESCI)

14. Clinical pharmacists in the healthcare system

SANCAR M.
Acta Pharmaceutica Sciencia , cilt.63, sa.4, 2025 (Scopus) identifier

15. Clinical pharmacist-led problem-specific education as a strategy for addressing suboptimal antimicrobial use in intensive care unit: a prospective pre-post analysis

İLERLER E. E., Ayhan Y. E., YALÇINKAYA E., KARAKURT S., SANCAR M.
Frontiers in Pharmacology , cilt.16, 2025 (SCI-Expanded) identifier identifier

16. PHARMACIST-DRIVEN MEDICATION REVIEW SERVICE IN PATIENTS WITH HEART FAILURE: A PROSPECTIVE STUDY KALP YETERSİZLİĞİ HASTALARINDA ECZACI ODAKLI İLAÇ İNCELEME HİZMETİ: PROSPEKTİF BİR ÇALIŞMA

Ustaömer S., SAYAR N., SÜNBÜL M., SANCAR M.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.49, sa.2, ss.447-458, 2025 (Scopus) identifier identifier

17. Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases

Samuelyan N., AY N. P., Moon Z., SANCAR M., Horne R., OKUYAN B.
European Journal of Clinical Pharmacology , cilt.80, sa.11, ss.1715-1723, 2024 (SCI-Expanded) identifier identifier

18. Assessment of drug-induced electrolyte disorders in intensive care units: a multicenter observational study

Ayhan Y. E., İLERLER E. E., Sosyal D., BEKTAY M. Y., KARAKURT S., DAŞKAYA H., et al.
Frontiers in Medicine , cilt.11, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

19. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic

ÜNDER D., ENVER C., DEMİRCİ M. Y., AYHAN Y. E., ÖZGAN B., İLERLER E. E., et al.
Turkish Journal of Pharmaceutical Sciences , cilt.21, sa.2, ss.152-158, 2024 (ESCI, Scopus, TRDizin) identifier identifier identifier

20. The impact of an education program on the appropriate prescription of proton pump inhibitors in hospitalized internal medicine services patients

AYHAN Y. E., ENVER C., OKUYAN B., KEKLİKKIRAN Ç., Azizy A., Yolcu T. K., et al.
Acta Pharmaceutica Sciencia , cilt.62, sa.1, ss.145-158, 2024 (Scopus) identifier

21. Factors associated with intention of clinical pharmacists and candidates to provide pharmaceutical care: application of theory planned behaviour

Tecen-Yucel K., Ozdemir N., Kara E., Demirkan K., Sancar M., Okuyan B.
BMC MEDICAL EDUCATION , cilt.23, sa.1, ss.682, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

22. Medication Reconciliation Service in Hospitalized Patients with Infectious Diseases During Coronavirus Disease-2019 Pandemic: An Observational Study

ENVER C., ERTÜRK ŞENGEL B., SANCAR M., KORTEN V., OKUYAN B.
Turkish Journal of Pharmaceutical Sciences , cilt.20, sa.4, ss.210-217, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

23. Reliability and validity of the Turkish version of the Family Caregiver Medication Administration Hassles Scale

Kingir Z. B., SANCAR M., AY N. P., Demirtunc R., Nuhoglu C., Misirli C. H., et al.
FAMILY PRACTICE , cilt.41, sa.4, ss.596-604, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

24. Atriyal Fibrilasyon ve İlişkili Risk Gruplarında Direkt Oral Antikoagülanların Kullanımı: Geleneksel Derleme

ayhan y. e., ÜNDER D., İLERLER E. E., MİDİ İ., SANCAR M.
Literatür Eczacılık Bilimleri Dergisi , cilt.12, sa.1, ss.72-81, 2023 (Hakemli Dergi) Creative Commons License identifier

25. Genel Pediatri Servisinde Kullanılan Pediatrik Dozaj Formu Olmayan İlaçların İncelenmesi: Tanımlayıcı Bir Çalışma

ayhan y. e., Enver C., OKUYAN B., BORAN P., SANCAR M.
Türkiye Klinikleri Pediatri Dergisi , cilt.32, sa.1, ss.36-41, 2023 (Scopus) Creative Commons License identifier identifier

26. Psychometric properties of the theory-based clinical behavioral intention scale among Turkish community pharmacists

OKUYAN B., ozcan V., AY P., DURAK ALBAYRAK Ö., TÜRKER M., UÇAR N., et al.
Journal of research in pharmacy (online) , cilt.27, sa.1, ss.464-468, 2023 (Scopus, TRDizin) Creative Commons License identifier identifier

27. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

BEKTAY M. Y., SANCAR M., OKYALTIRIK F., DURDU B., İZZETTİN F. V.
Frontiers in Pharmacology , cilt.13, 2023 (SCI-Expanded) identifier identifier identifier

28. INTERVENTIONS IN INTERNAL MEDICINE WARDS WITH SCOPE OF CLINICAL PHARMACY RESIDENCY PROGRAM: A RETROSPECTIVE STUDY KLİNİK ECZACILIK UZMANLIK PROGRAMI KAPSAMINDA İÇ HASTALIKLARI SERVİSLERİNDEKİ MÜDAHALELER: RETROSPEKTİF BİR ÇALIŞMA

AYHAN Y. E., SANCAR M.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.47, sa.2, ss.557-566, 2023 (Scopus) identifier identifier

29. Medication adherence barriers in Turkish patients with chronic diseases

Yagmur M., SANCAR M., Ay P., Abdi A., Samuelyan N., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.6, ss.1480, 2022 (SCI-Expanded) identifier

30. Development of virtual education module to promote Turkish community pharmacist-led pharmaceutical care services in older patients

OKUYAN B., Ozcan V., Balta E., Albayrak O. D., Turker M., SANCAR M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.6, ss.1504, 2022 (SCI-Expanded) identifier

31. Intentional medication adherence problems in Turkish older patients

OKUYAN B., Ozcan V., Balta E., Albayrak O. D., Turker M., SANCAR M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.6, ss.1503-1504, 2022 (SCI-Expanded) identifier

32. Assessment of medication literacy in breastfeeding women: preliminary data

Ucar N., SANCAR M., Sezerol M. A., Buyukkayh D., Tasci Y., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.6, ss.1560, 2022 (SCI-Expanded) identifier

33. Development of a Theory Planned Behavior based scale to assess Turkish clinical pharmacists' intention to provide pharmaceutical care

ÖZDEMİR N., Tecen-Yucel K., KARA E., Demirkan K., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.6, ss.1487, 2022 (SCI-Expanded) identifier

34. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study

AYHAN Y. E., KARAKURT S., SANCAR M.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.47, sa.11, ss.1867-1874, 2022 (SCI-Expanded) identifier identifier identifier

35. Medication Review in Turkish Older Adults at Community Pharmacy: A Pilot Study by Using Medication Appropriateness Index

Dal S., Ucar N., ALTIPARMAK Ö., SANCAR M., OKUYAN B.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.12, sa.3, ss.725-729, 2022 (ESCI) Creative Commons License identifier identifier

36. Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting

Sayin Z., SANCAR M., Ozen Y., OKUYAN B.
ACTA CLINICA BELGICA , cilt.77, sa.2, ss.273-279, 2022 (SCI-Expanded) identifier identifier identifier

37. Factors associated with Turkish pharmacists' intention to receive COVID-19 vaccine: an observational study

OKUYAN B., Bektay M. Y., DEMİRCİ M. Y., AY N. P., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.1, ss.247-255, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

38. Therapeutic Drug Monitoring in Pediatric Patients Treated with Anti-Tuberculosis Medications by High Performance Liquid Chromatography

Okuyan B., Tok F., Karakuş S., Dalgiç N., Çakır E., Midyat L., et al.
Journal of Research in Pharmacy , cilt.26, sa.6, ss.1907-1914, 2022 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

39. Assessment of drug-related problems in pediatric inpatients by clinical pharmacist-led medication review: An observational study

ŞAHİN Y., Nuhoglu C., OKUYAN B., SANCAR M.
JOURNAL OF RESEARCH IN PHARMACY , cilt.26, sa.4, ss.1007-1015, 2022 (ESCI) Creative Commons License identifier identifier identifier

40. Reliability of High-Alert Medications Questionnaire in Turkish Healthcare Professionals

Ozturk F., Altiparmak O., Torun B., Bektay M. Y., SANCAR M., OKUYAN B.
BEZMIALEM SCIENCE , cilt.10, sa.1, ss.17-23, 2022 (ESCI) identifier identifier

41. The impact of clinical pharmacist-led hypertension screening at the community pharmacy in Türkiye

Demircioglu Akyilmaz C. E., OKUYAN B., SANCAR M.
Journal of Research in Pharmacy , cilt.26, sa.6, ss.1900-1906, 2022 (ESCI) identifier identifier identifier

42. Pediatric Patients with COVID-19: A Retrospective Single-Center Experience

Sahin A., Dalgic N., SANCAR M., Congur E. C., Kanik M. K., Ilgar S. D., et al.
MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , cilt.56, sa.1, ss.62-69, 2022 (ESCI) Sürdürülebilir Kalkınma identifier identifier

43. Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward

CEYLAN C., SANCAR M., BECEREN A., Demir A., KUŞ C., Omurtag G. Z.
JOURNAL OF RESEARCH IN PHARMACY , cilt.26, sa.3, ss.687-696, 2022 (ESCI) Creative Commons License identifier identifier identifier

44. Investigation of pharmaceutical care need of COVID-19 patients in hospital settings

BEKTAY M. Y., SANCAR M., OKYALTIRIK F., DURDU B., İZZETTİN F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1777-1778, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

45. Evaluation of clinical pharmacy services in pediatric nephrology service

GÜN Z. Ü., AKSOY N., TABEL Y., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1784, 2021 (SCI-Expanded) identifier

46. Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout

Okuyan B., Bektay M. Y., Kingir Z. B., Save D., Sancar M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.12, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

47. Clinical pharmacist-led medication reconciliation service in patients with infectious disease during COVID-19 pandemic

Enver C., Ertürk Şengel B., Sancar M., Korten V., Okuyan B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1770, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

48. Psychometric properties of the Turkish version of the family caregiver medication administration hassles scale

Kingir Z. B., SANCAR M., Demirtunc R., Nuhoglu C., Misirli C. H., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1765, 2021 (SCI-Expanded) identifier

49. Adaptation of Chronic Kidney Disease-Self Management Knowledge Tool (CKD-SMKT) into Turkish

ALTIPARMAK Ö., İZZETTİN F. V., OKUYAN B., ARIKAN İ. H., SANCAR M.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.11, sa.3, ss.432-436, 2021 (ESCI) identifier identifier

50. Validation of a Knowledge Test in Turkish Patients on Warfarin Therapy at an Ambulatory Anticoagulation Clinic

Türker M., SANCAR M., DEMİRTUNÇ R., UÇAR N., Osman U., AY N. P., et al.
Turkish journal of pharmaceutical sciences , cilt.18, ss.445-451, 2021 (ESCI) identifier identifier identifier identifier

51. Turkish community pharmacists' behavioral determinants in provision of pharmaceutical care to elderly patients

OKUYAN B., Balta E., Ozcan V., Durak Albayrak O., Turker M., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.4, ss.1024-1035, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

52. Impact of Clinical Pharmacist-led Interventions in Turkey

KARA E., cakir B. K., SANCAR M., DEMİRKAN S. K.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.18, sa.4, ss.517-526, 2021 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier identifier

53. QT prolongation risk with antiemetics during COVID 19 treatment

AKSOY N., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

54. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey

Hagens A., İNKAYA A. Ç., YILDIRAK Ş. K., SANCAR M., van der Schans J., Sancar A. A., et al.
VACCINES , cilt.9, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

55. Hastanede Yatan Pediatrik Hastalarda İlaç Tedavisinin İncelenmesi: Klinik Eczacı Önerileri

Işık M. N., DALGIÇ N., OKUYAN B., YILDIRMAK Z. Y., SANCAR M.
Çocuk Enfeksiyon Dergisi , cilt.14, sa.4, ss.1-5, 2020 (ESCI) identifier

56. Comparison of non-burn-specific systemic inflammatory response syndrome criteria and burn-specific American Burn Association systemic inflammatory response syndrome criteria in paediatric burned patients

Dalgic N., Sahin A., Karadag C. A., SANCAR M.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH , cilt.56, sa.10, ss.1623-1628, 2020 (SCI-Expanded) identifier identifier identifier

57. Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study

Oncel I., SANCAR M., Konuskan B., Arioz F., TEZCAN S., Arman-Kandirmaz E., et al.
Pediatric Neurology , cilt.110, ss.59-63, 2020 (SCI-Expanded) identifier identifier identifier

58. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting

Al-Taie A., Izzettin F., SANCAR M., Koseoglu A.
EUROPEAN JOURNAL OF CANCER CARE , cilt.29, sa.5, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

59. Impact of Verbal and Web-based Patient Education Programs Driven by Clinical Pharmacist on the Adherence and Illness Perception of Hypertensive Patients

YILMAZ Z., SANCAR M., OKUYAN B., YEŞİLDAĞ O., İzzettin F. V.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH , cilt.54, sa.3, 2020 (SCI-Expanded) identifier identifier

60. A PILOT STUDY OF CLINICAL PHARMACIST-LED MEDICATION REVIEW IN OLDER ADULTS ON POLYPHARMACY AND RECEIVING HOME HEALTH CARE SERVICES

Memis S., SANCAR M., Varlikli O., Akcay B., Varol H., SÖYLEMEZ S. L., et al.
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.23, sa.4, ss.515-523, 2020 (SCI-Expanded) Creative Commons License identifier identifier

61. Assessment of the pharmacy students' e-health literacy and mobile health application utilization

Ustun G., SÖYLEMEZ S. L., Ucar N., SANCAR M., OKUYAN B.
JOURNAL OF RESEARCH IN PHARMACY , cilt.24, sa.1, ss.23-29, 2020 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

62. Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit

Paksoy C., Ozkan O., Ustaalioglu B. B. O., SANCAR M., Demirtunc R., Izzettin F. V., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.6, ss.1321-1327, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

63. Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting

SANCAR M., Kasik A., OKUYAN B., Batuhan S., Izzettin F. V.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.16, sa.1, ss.14-19, 2019 (ESCI, Scopus, TRDizin) identifier identifier identifier

64. Evaluation of satisfaction and internet self-efficacy of inquirers using an internet-based drug information centre

İZZETTİN F. V., özden z. k., OKUYAN B., SANCAR M.
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES , cilt.14, sa.1, ss.67-72, 2019 (ESCI) identifier identifier identifier

65. Evaluation of knowledge and attitude of pharmacist and pharmacy technicians on emergency contraception method in Istanbul, Turkey: A simulated patient study

uzun g. d., SANCAR M., OKUYAN B.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.3, ss.395-402, 2019 (ESCI) Sürdürülebilir Kalkınma identifier identifier

66. The Clinical and Economic Outcomes of the Pharmacist Involved-Antimicrobial Stewardship Programs

SANCAR M., Ünal Sayın Z., Cankatar S., DALGIÇ N., OKUYAN B.
Literatür Eczacılık Bilimleri Dergisi , cilt.8, sa.1, ss.18-28, 2019 (Hakemli Dergi)

67. The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment

İZZETTİN F. V., Çelik S., Acar R. D., TEZCAN S., AKSOY N., Bektay M., et al.
journal of research in Pharmacy , cilt.23, sa.6, ss.1157-63, 2019 (ESCI) identifier identifier

68. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey

Abunahlah N., Elawaisi A., Velibeyoglu F. M., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.2, ss.360-367, 2018 (SCI-Expanded) identifier

69. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer

TEZCAN S., Izzettin F. V., SANCAR M., Turhal N. S., YUMUK P. F.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE , cilt.25, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

70. Assessment of knowledge and attitude of women utilized oral contraception

Kursun H., OKUYAN B., Barri R., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.235, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

71. Drug related problems identified by clinical pharmacist at the internal medicine ward

Abunahlah N., El-Awaisi A., Velibeyoglu F. M., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.244-245, 2018 (SCI-Expanded) identifier

72. Evaluation of antihypertensive medication adherence at community pharmacy setting

Cakir N., OKUYAN B., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.235, 2018 (SCI-Expanded) identifier

73. The Evaluation of Parents Attitude Towards Antibiotic Use In Children In The Age of Primary School

Ak D., Izzetttin F. V., OKUYAN B., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.311, 2018 (SCI-Expanded) identifier

74. Potential drug interactions with cigarette smoking at community pharmacy setting

Ozbey S., Uzun G. D., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.238, 2018 (SCI-Expanded) identifier

75. Importance of medication dose adjustment in hospitalized patients with impaired renal function at internal medicine ward: the possible impact of clinical pharmacist

Altan A., Ozkan O., Demirtunc R., OKUYAN B., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.275, 2018 (SCI-Expanded) identifier

76. The role of clinical pharmacist in evaluation of cardiometabolic risk and drug-related problems in patients with bipolar disorder

Yang S., OKUYAN B., SANCAR M., BİNGÖL ÖZAKPINAR Ö., Nebioglu M., Caliskan M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.273, 2018 (SCI-Expanded) identifier

77. Attitudes of visually disabled people towards medication usage-primary research

Belentepe A., Ozkan O., Leblebici A., Ozdemir B., Ince I., Torun B., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.215-216, 2018 (SCI-Expanded) identifier

78. Assessment of Self-care and Fear of Self-injecting and Self-testing in Diabetic Patients Utilized Insulin

Ozelci T., Ozkan O., Torun B., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.233, 2018 (SCI-Expanded) identifier

79. Evaluation of the different patient education methods given by the clinical pharmacist

Yilmaz Z. K., SANCAR M., OKUYAN B., YEŞİLDAĞ O., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.243-244, 2018 (SCI-Expanded) identifier

80. Evaluation of Pharmacists' Role Related to Corticosteroid Usage: Corticophobia

Izzettin F. V., TEZCAN S., Cakici G., ŞAHİN Y., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.243, 2018 (SCI-Expanded) identifier

81. Medication adherence and medication regimen complexity of patients with polypharmacy at community pharmacy setting

Leblebici A., Torun B., Ozkan O., Ozdemir B., Belentepe A., Ince I., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.237, 2018 (SCI-Expanded) identifier

82. Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats

Bami E., BİNGÖL ÖZAKPINAR Ö., ÖZDEMİR KUMRAL Z. N., Koroglu K., ERCAN F., Cirakli Z., et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , cilt.54, ss.105-111, 2017 (SCI-Expanded) identifier identifier identifier

83. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial

Korcegez E. I., SANCAR M., Demirkan K.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY , cilt.23, sa.5, ss.573-582, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

84. ASSESSMENT OF URINARY 8-HYDROXYDEOXYGUANOSINE LEVEL IN DIABETIC CANCER PATIENTS

Al-Taie A., Izzettin F. V., SANCAR M., Koseoglu A., Aliustaoglu M., Kaptanagasi A.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH , cilt.8, sa.4, ss.1619-1623, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

85. Evaluation of rational antibiotic dispensing in the community pharmacy setting: a simulated patient study

OKUYAN B., Savan M. A., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.246-247, 2017 (SCI-Expanded) identifier

86. Investigation of medication profile of patients during hospital admission

Odabasi G., OKUYAN B., SANCAR M., Izzettin F. V., Demirtunc R.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.298, 2017 (SCI-Expanded) identifier

87. The evaluation of elderly patients' medication profile at community pharmacy setting

OKUYAN B., Atakul N., Ozkan O., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.248, 2017 (SCI-Expanded) identifier

88. Assessment of port-catheter complications in cancer patients: impact of clinical pharmacist care

Koseoglu A., Al-Taie A. H., Aliustaoglu M., SANCAR M., Izzettin F.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.263, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

89. Determination of medication adherence in hypertensive patients in Turkey and North Cyprus

Zengin D., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.248, 2017 (SCI-Expanded) identifier

90. Impact of antiemetic guideline consistency on the patient's quality of life

Abunahlah N., Alqozbakr T., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.321, 2017 (SCI-Expanded) identifier

91. Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients

Izzettin F. V., Al-taie A., SANCAR M., Aliustaoglu M.
MARMARA PHARMACEUTICAL JOURNAL , cilt.21, sa.3, ss.603-611, 2017 (ESCI) Sürdürülebilir Kalkınma identifier

92. Determination of side effects and medication adherence in major depression patients utilized antidepressants

SANCAR M., Duzgun E., OKUYAN B., Deniz S., Caliskan M., Coskun K., et al.
MARMARA PHARMACEUTICAL JOURNAL , cilt.21, sa.1, ss.177-182, 2017 (ESCI) identifier identifier

93. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life

Abunahlah N., SANCAR M., DANE F., Ozyavuz M. K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.6, ss.1464-1476, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

94. Kronik Hastalarda Hasta Odaklı Eczacılık Hizmetleri ile ilgili Memnuniyet Anketinin Türkçe Validasyonu

OKUYAN B., Hücum H., SANCAR M., AY N. P., İZZETTİN F. V.
Clinical Experimental Health Science , cilt.6, sa.4, ss.150-154, 2016 (Hakemli Dergi)

95. Ethanol extract of Cotinus coggygria leaves accelerates wound healing process in diabetic rats

Aksoy H., ŞEN A., SANCAR M., ŞEKERLER T., AKAKIN D., BİTİŞ L., et al.
PHARMACEUTICAL BIOLOGY , cilt.54, sa.11, ss.2732-2736, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

96. Validation of the Turkish version of medication regimen complexity index among elderly patients

OKUYAN B., Babi B., SANCAR M., Ay P., Yucel E., Yucel A., et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE , cilt.22, sa.5, ss.732-736, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

97. Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

Deniz S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., Talas A., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.26, sa.2, ss.152-160, 2016 (SCI-Expanded) Creative Commons License identifier identifier

98. Observation of radiotherapy related acute side effects occurrence and management in cancer patients

ALTAİE A., KÖSEOĞLU A., İZZETTİN F. V., SANCAR M., TEZCAN S., ALQOZBAKR T. A. B., et al.
INTERNATIONAL JOURNAL OF PHARMACY , cilt.6, ss.11-19, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

99. Adverse drug reactions due to drug- drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method

Yucel E., SANCAR M., Yucel A., OKUYAN B.
EXPERT OPINION ON DRUG SAFETY , cilt.15, sa.2, ss.223-236, 2016 (SCI-Expanded) identifier identifier identifier

100. Hipertansiyonda Farmasötik Bakım

SANCAR M., OKUYAN B.
Sanayi Eczacılarının Sesi Dergisi , cilt.7, ss.12-17, 2016 (Hakemsiz Dergi)

101. Turkish Validation of Patient Satisfaction Towards Patient Oriented Pharmacy Services Questionnaire in Patients with Chronic Disease

OKUYAN B., Hucum H., SANCAR M., Ay P., Izzettin F. V.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.6, sa.4, ss.150-154, 2016 (ESCI) identifier

102. The effect of topical ethanol extract of Cotinus coggygria Scop. on cutaneous wound healing in rats

Aksoy H., SANCAR M., ŞEN A., OKUYAN B., BİTİŞ L., Uras F., et al.
NATURAL PRODUCT RESEARCH , cilt.30, sa.4, ss.452-455, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

103. The effect of pharmacist-led education on inhaler use skills in hospitalised patients with chronic obstructive pulmonary disease

SANCAR M., Sirinoglu Y., OKUYAN B., Karagoz T., Izzettin F. V.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY , cilt.22, sa.6, ss.366-368, 2015 (SCI-Expanded) identifier identifier

104. Assessment of the Attitude of Community Pharmacists and Pharmacy Technicians towards Diarrhea: A Simulated Patient Study in Turkey

SANCAR M., Tezcan E., OKUYAN B., Izzettin F. V.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , cilt.14, sa.8, ss.1509-1515, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

105. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting

DİNLEYİCİ E. Ç., Dalgic N., Guven S., Metin O., Yasa O., Kurugol Z., et al.
JORNAL DE PEDIATRIA , cilt.91, sa.4, ss.392-396, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

106. Assessment of knowledge and attitude towards osteoporosis among women attending community pharmacy settings

OKUYAN B., Acar M. A., Kilic B., Kome H., Bami E., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.213, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

107. Assessment of patients' knowledge and attitude towards methotrexate utilization

Dumlu H. I., OKUYAN B., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.256, 2015 (SCI-Expanded) identifier

108. Determination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors

Deniz S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., Talas A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.231-232, 2015 (SCI-Expanded) identifier

109. Evaluation of drug burden index and medication utilization in geriatric patients at community pharmacy

SANCAR M., Girgin I., Selcuk A., Yang S., Izzettin F. V., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.206-207, 2015 (SCI-Expanded) identifier

110. Evaluation of drug burden index in elderly patients utilized inhaler

OKUYAN B., Aydinli Z., ÇELİK İ., Dincel E. D., Say T., Yavuz D., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.205, 2015 (SCI-Expanded) identifier

111. Determination of drug related problem and drug burden index in elderly patients

OKUYAN B., Aydinli Z., ÇELİK İ., Dincel E. D., Say T., Yavuz D., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.208-209, 2015 (SCI-Expanded) identifier

112. The role of pharmacist in detecting angiotensin converting enzyme inhibitors induced dry cough at community pharmacy setting

Atalay G. C., SANCAR M., OKUYAN B., Atalay S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.207, 2015 (SCI-Expanded) identifier

113. Evaluation of drug burden index in elderly patients utilized disposable insulin pen

OKUYAN B., Aydinli Z., ÇELİK İ., Dincel E. D., Say T., Yavuz D., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.203-204, 2015 (SCI-Expanded) identifier

114. Antimikrobiyal Yönetim Programlarında Klinik Eczacı Etkisi

OKUYAN B., SANCAR M.
Sanayi Eczacılarının Sesi Dergisi , sa.6, ss.16-18, 2015 (Hakemsiz Dergi)

115. Ertapenem versus Standard Triple Antibiotic Therapy for the Treatment of Perforated Appendicitis in Pediatric Patients: A Prospective Randomized Trial

Dalgic N., Karadag C. A., Bayraktar B., SANCAR M., Kara O., Pelit S., et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY , cilt.24, sa.5, ss.410-418, 2014 (SCI-Expanded) identifier identifier identifier

116. The implementation of pharmacist driven medication reconciliation program at the admission to hospital

SANCAR M., DEMİR ÖZKER P., ER E., TURAN B., OKUYAN B.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.4, sa.4, ss.226-231, 2014 (ESCI) identifier

117. Eczacılıkta yeni dönem Klinik eczacılık ve sağlık sistemindeki yeri

AYPAR E., SANCAR M., İZZETTİN F. V.
Sağlık Düşüncesi ve tıp kültürü dergisi , sa.30, ss.48-51, 2014 (Hakemsiz Dergi)

118. Yaşlılarda İlaç Kullanımı Eczacı Perspektifi

OKUYAN B., SANCAR M.
Sanayi Eczacılarının Sesi Dergisi , cilt.5, ss.19-22, 2014 (Hakemsiz Dergi)

119. Attitude and Knowledge of Hospitalized Patients with Type 2 Diabetes Mellitus Towards Disposable Insulin Pens Utilization

OKUYAN B., SAĞLAM B., EMRE E., DEMİRTUNÇ R., İZZETTİN F. V., SANCAR M.
MARMARA PHARMACEUTICAL JOURNAL , cilt.18, sa.3, ss.159-163, 2014 (ESCI) identifier identifier

120. Nephrotoxicity Evaluation in Outpatients Treated withCisplatin Based Chemotherapy Using a Short HydrationMethod

TEZCAN S., İZZETTİN F. V., SANCAR M., YUMUK P. F., TURHAL N. S.
pharmacology and pharmacy , cilt.4, ss.296-302, 2013 (Hakemli Dergi)

121. The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: Single blinded randomized study

DİNLEYİCİ E. Ç., Dalgic N., Guven S., Ozen M., KARA A., Arica V., et al.
EUROPEAN JOURNAL OF PEDIATRICS , cilt.172, sa.4, ss.459-464, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

122. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings

OKUYAN B., SANCAR M., Izzettin F. V.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , cilt.22, sa.2, ss.209-214, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

123. Opinion and Knowledge Towards Pharmaceutical Care Of The Pharmacists Participated in Clinical Pharmacy and Pharmaceutical Care Continuing Education Program

SANCAR M., OKUYAN B., RABUŞ Ş., İZZETTİN F. V.
Turkish Journal of Pharmaceutical Sciences , cilt.10, sa.2, ss.245-254, 2013 (Scopus)

124. Assessment of levofloxacın effect on human neutrophil functions in vitro

CÖMERTER H., KADİR T., OKUYAN B., SANCAR M., İZZETTİN F. V.
Turkish Journal of Pharmaceutical Sciences , cilt.10, sa.1, ss.19-24, 2013 (Hakemli Dergi) identifier identifier

125. Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats

Izzettin F. V., SANCAR M., OKUYAN B., Apikoglu-Rabus S., Cevikbas U.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , cilt.64, sa.4, ss.339-343, 2012 (SCI-Expanded) identifier identifier identifier

126. The Effects Of Ginkgo Biloba On Nephrotoxicity Induced By Cisplatin based Chemotherapy Protocols In Rats

OKUYAN B., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., TURAN P., ÖZDEMİR KUMRAL Z. N., SANCAR M., et al.
IUFS Journal of Biology , cilt.71, ss.103-111, 2012 (Hakemli Dergi)

127. Bir serbest eczanede eczacı danışmanlığında yürütülen sigara bırakma programının sonuçlarının değerlendirilmesi

ATALAY L., SANCAR M., OKUYAN B., İZZETTİN F. V.
MÜSBED , cilt.2, sa.1, ss.20-25, 2012 (Hakemli Dergi)

128. The impact of pharmacist-led smoking cessation program at community pharmacy

Atalay L., SANCAR M., OKUYAN B., Izzettin F. V.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.2, sa.1, ss.20-25, 2012 (ESCI) Sürdürülebilir Kalkınma identifier

129. Solunum Yoluyla İlaç Kullanımı ve Eczacı Danışmanlığı

SANCAR M.
Herkese Sağlık , cilt.16, ss.38-44, 2012 (Hakemsiz Dergi)

130. Göz Burun ve Kulağa İlaç Uygularken

SANCAR M.
Herkese Sağlık , cilt.17, ss.36-40, 2012 (Hakemsiz Dergi)

131. Probiotic, zinc and lactose-free formula in children with rotavirus diarrhea: Are they effective?

Dalgic N., SANCAR M., Bayraktar B., Pullu M., Hasim O.
PEDIATRICS INTERNATIONAL , cilt.53, sa.5, ss.677-682, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

132. Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis

Dalgic N., Tekin D., Kayaalti Z., Soylemezoglu T., Cakir E., Kilic B., et al.
HUMAN IMMUNOLOGY , cilt.72, sa.5, ss.440-445, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

133. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase-producing bacteria in children

Dalgic N., SANCAR M., Bayraktar B., Dincer E., Pelit S.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , cilt.43, sa.5, ss.339-343, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

134. Alendronat tedavisinin senil osteoporozlu hastalarda idrar kalsiyum kreatinin oranı üzerine etkisinin değerlendirilmesi

YÖRÜKOĞLU E., OKUYAN B., SANCAR M., İZZETTİN F. V.
MÜSBED , cilt.1, sa.1, ss.42-46, 2011 (Hakemli Dergi)

135. Eczanelerde Klinik Eczacılık Ve Farmasötik Bakım Hizmetleri Verilebilir Mi

İZZETTİN F. V., SANCAR M., OKUYAN B.
Ecza Yaşam , cilt.3, sa.8, ss.50-51, 2011 (Hakemsiz Dergi)

136. Klinik Eczacıların Uzmanlık Alanları

OKUYAN B., SANCAR M.
Sentez , cilt.7, ss.12-13, 2011 (Hakemsiz Dergi)

137. Turkish pharmacy technicians' counseling practices and attitudes regarding emergency contraceptive pills

Apikoglu-Rabus S., SANCAR M., OKUYAN B., Izzettin F. V.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.5, sa.1, ss.60-66, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

138. Assesment of the effect of alendronate therapy on urine calcium/creatinine ratio in patients with senil osteoporosis

Yorukoglu E., OKUYAN B., SANCAR M., Izzettin F. V.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.1, sa.1, ss.42-46, 2011 (ESCI) identifier

139. Serbest Eczanelerde Klinik Eczacılık ve Farmasötik Bakım Hizmetleri

OKUYAN B., SANCAR M., İZZETTİN F. V.
İlaç Haber Aktüel, 25: 10 (2011). , cilt.25, sa.10, 2011 (Hakemsiz Dergi)

140. Linezolid treatment of shunt-related cerebrospinal fluid infections in children Clinical article

Yilmaz A., Dalgic N., Musluman M., SANCAR M., Colak I., Aydin Y.
JOURNAL OF NEUROSURGERY-PEDIATRICS , cilt.5, sa.5, ss.443-448, 2010 (SCI-Expanded) identifier identifier identifier

141. Medication use evaluation during acute exacerbation and stable periods in patients with chronic obstructive pulmonary disease

Soydeger-Carli B., SANCAR M., OKUYAN B., Carli O., Karagoz T., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.32, sa.2, ss.306, 2010 (SCI-Expanded) identifier

142. Is Rotavirus Diarrhea a Systemic Viral Infection

DALGIC N., HASIM O., PULLU M., SANCAR M., KAFADAR I., YILMAZ A.
Çocuk Enfeksiyon Dergisi , cilt.4, sa.4, ss.48-55, 2010 (Scopus) Sürdürülebilir Kalkınma

143. Comparative effectiveness of Glycyrrhiza glabra vs. omeprazole and misoprostol for the treatment of aspirin-induced gastric ulcers

SANCAR M., Hantash T., OKUYAN B., Apikoglu-Rabus S., Cirakli Z., Gulluoglu M. G., et al.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.3, sa.12, ss.615-620, 2009 (SCI-Expanded) identifier identifier

144. Improvement of diabetes indices of care by a short pharmaceutical care program

Turnacilar M., SANCAR M., Apikoglu-Rabus S., Hursitoglu M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.31, sa.6, ss.689-695, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

145. Community pharmacists' opinion on pharmaceutical care practice in Turkey

SANCAR M., OKUYAN B., RABUŞ Ş., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.97, 2009 (SCI-Expanded) identifier

146. The quality of life and pharmaceutical care requirements of the hypertension patients in a community pharmacy

Izzettin F. V., Nakiboglu V. S., SANCAR M.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.98, 2009 (SCI-Expanded) identifier

147. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease

RABUŞ Ş., Izzettin F. V., SANCAR M., Karakaya O., Kargin R., Yakut C.
PHARMACY WORLD & SCIENCE , cilt.30, sa.6, ss.753-758, 2008 (SCI-Expanded) identifier identifier identifier

148. The role of community pharmacist on oral and dental health: prevention of diseases and toothache management

Tunc S., SANCAR M., Sarica P., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.716, 2008 (SCI-Expanded) identifier

149. An evaluation of systemic and topical treatments of otitis media: a hospital study in Turkey

Eken M., OKUYAN B., SANCAR M., Eken M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.731-732, 2008 (SCI-Expanded) identifier

150. Determination of geriatric patients' drug profile and identify their pharmaceutical care requirement

Yalcin B., SANCAR M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.705-706, 2008 (SCI-Expanded) identifier

151. The incidence of dry cough in angiotensin-converting enzyme inhibitor users

Ozyalcin M., SANCAR M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.715-716, 2008 (SCI-Expanded) identifier

152. Klinik Eczacılık ve Farmasötik Bakım Meslek içi Eğitim Programları

SANCAR M.
TEB Haberler , cilt.5, ss.32-33, 2008 (Hakemsiz Dergi)

153. Cardiovascular drug prescription in type 2 diabetes

Izzettin F. V., Rabus S. A., Sancar M., Gebeloglu N., Hursitoglu M.
PHARMACY WORLD & SCIENCE , cilt.29, sa.5, ss.513-514, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

154. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens

Sancar M., Izzettin F. V., Apikoglu-Rabus S., Besisik F., Tozun N., Dulger G.
PHARMACY WORLD & SCIENCE , cilt.28, sa.4, ss.207-214, 2006 (SCI-Expanded) identifier

155. Nephrotoxicity of Piroxicam in Rats

Ahmed E. Y., İzzettin F. V., Ayça İ. B., Sancar M., Stohs S. J.
Research Communication in Pharmacology and Toxicology , cilt.8, ss.27-33, 2003 (Hakemli Dergi) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 173

1. Evaluation of Questions Posed to the Clinical Pharmacist in the Medical Intensive Care Unit in Türkiye: A Descrirptive Study

AKSOY M., TEZCAN S., KARAKURT S., SANCAR M.
2025 ACCP Virtual Poster Symposium, Amerika Birleşik Devletleri, 20 - 21 Mayıs 2025, (Özet Bildiri)

2. Karar Noktasında Klinik Eczacı: Yoğun Bakım Ünitesinde İlaç Yönetiminde Sık Karşılaşılan Sorular Üzerine Bir İnceleme İlaç Danışmanı Olarak Klinik Eczacı

AKSOY M., SANCAR M., KARAKURT S., TEZCAN S.
MUEFKON, İstanbul, Türkiye, 8 - 10 Mayıs 2025, (Özet Bildiri)

3. KNOWLEDGE, ATTITUDE AND PRACTICES OF DENTISTS ABOUT ANTITHROMBOTIC MEDICATIONS: PRE-POST TEST

YÜRÜK F. U., TEZCAN S., CENGİZ A., SANCAR M.
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice, Krakow, Polonya, 21 Ekim 2024, (Özet Bildiri)

4. THERAPEUTIC DRUG MONITORING OF APREPITANT WITH LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY

TEZCAN S., Kunal G., ÖZDEMİR F., ARMAN KANDIRMAZ E., SANCAR M.
ESCP Aberdeen Symposium 2023: Innovations in Clinical Pharmacy Practice, Education and Research, Aberdeen, İngiltere, 31 Ekim 2023, (Özet Bildiri)

5. Yenidoğan Terapötik Hipotermi Tedavisinde Değişen Farmakokinetik: Bir Olgu Raporu

ÖZGAN B., ÖZEK E., SANCAR M.
3. Olgularla Klinik Eczacılık Çalıştayı, Türkiye, 14 - 17 Haziran 2023, (Özet Bildiri)

6. Pulmoner Arteriyal Hipertansiyonlu Bir Olguda Sildenafil’den Riosiguat’a Geçiş

ÖZGAN B., DEMİRCİ M. Y., ATAŞ H., MUTLU B., SANCAR M.
Olgularla Klinik Eczacılık Çalıştayı, Türkiye, 17 Haziran 2021, (Özet Bildiri)

7. Clinical pharmacist-led medication reconciliation service in patients with infectious disease during COVID-19 pandemic

ENVER C., ERTÜRK ŞENGEL B., SANCAR M., KORTEN V., OKUYAN B.
49th ESCP virtual symposium on clinical pharmacy, Hollanda, 19 - 21 Ekim 2021, cilt.43, ss.1770, (Özet Bildiri)

8. The Psychometric Properties of the Mini-Cog© in Turkish Elderly Patients.

UÇAR N., ŞAHİN Y., ALTIPARMAK Ö., SANCAR M., DEMİRTUNÇ R., Süer D., et al.
ACCP Virtual Poster Symposium, May 26 and 27, 2020, Amerika Birleşik Devletleri, 26 - 27 Mayıs 2020, cilt.3, ss.1201, (Özet Bildiri)

9. Evaluation of the Quality of Life, Attitudes and Perceptions in Patients with Benign Prostatic Hyperplasia,

İZZETTİN F. V., ALGORANE I., OKUYAN B., SANCAR M., CAM H. K.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

10. Pharmacy Students’ Knowledge and Perception on High-Alert Medications

POZE T., TORUN B., ALTIPARMAK Ö., SANCAR M., OKUYAN B.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

11. The Evaluation of Type 2 Diabetes Mellitus Risk Screening at Community Pharmacy Setting

AYGÜN L., KÖSE H., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

12. The Attitude and Knowledge of Patients towards Medication Adherence and Wastage.

ALTIPARMAK Ö., TORUN B., YEŞİL DEVECİOĞLU T., SANCAR M., OKUYAN B.
48th ESCP Symposium on Clinical Pharmacy The Digital Revolution: Supporting clinical pharmacy through e-health, digital support systems, big data and more., 23 - 25 Ekim 2019

13. An Assessment of Parents’ Attitudes towards the Use of Medicines in Their Children: Preliminary Results

HACIYEV U., TORUN B., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

14. Evaluation of Medication Regimen Complexity and Medication Adherence in Patients with Benign Prostatic Hyperplasia

ALGORANE I., OKUYAN B., SANCAR M., İZZETTİN F. V., CAM H. K.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

15. Assessment Quality of Life in Patients Treated with Hyaluronic Acid for Knee Osteoarthritis: Case Control

TUNCER M., SÖYLEMEZ S. L., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

16. Clinical Pharmacists-Led Medication Review for Pediatric Patients at Hospital Setting

IŞIK M., DAGIÇ N., OKUYAN B., YILDIRMAK Z., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

17. E-Health Literacy and Mobile Application Utilization Among Pharmacy Students

ÜSTÜN G., SÖYLEMEZ S. L., UÇAR N., SANCAR M., OKUYAN B.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Evaluation of Diabetic Patients’ Medication Adherence and Attitudes towards Diabetic Foot Care

SEVİK F., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Medication Review in Elderly Patients at Community Pharmacy Setting: The Association Between Occurrence of Potentially Inappropriate Prescribing and Medication Regimen Complexity

SAYIN Z., ÖZEN Y., SANCAR M., OKUYAN B.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

20. Evaluation of Parents’ Knowledge and Attitude about Antipyretics

BAHADIR A., İZZETTİN F. V., ŞAHİN Y., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

21. Türkiye’de klinik eczacılık eğitiminin gelişimi: Marmara modeli”

SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

22. Marmara Üniversitesi’nde eczacılıkta uzmanlık eğitimi: İlk deneyimler

SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

23. All you need to know about clinical rounds: from design to assessment.

İZZETTİN F. V., RABUŞ Ş., SANCAR M.
ESCP47th European Symposium on Clinical Pharmacy, 24 - 26 Ekim 2018

24. Evaluatıon of knowledge and attıtudes of patıents and pharmacısts on usıng herbal products.

TEZCAN S., KIZILKAYA M., SANCAR M., İZZETTİN F. V.
47th ESCP Symposium on Clinical Pharmacy ”Personalised Pharmacy Care, Belfast, İrlanda, 24 - 26 Ekim 2018, (Özet Bildiri)

25. Evaluatıon of knowledge and attıtudes of patıents usıng eye drops / oıntments.

KILIÇASLAN Ö., SANCAR M., TEZCAN S., İZZETTİN F. V.
12th International Symposium on Pharmaceutical Sciences (ISOPS-12)., Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

26. MARMARA ECZACILIK STAJ EĞİTİMİNDE SÖZLÜ STAJ GÜNLERİ

UĞURLU T., ŞENER A., KERİMOĞLU O., SANCAR M., KARAKUŞ S., KAYMAKÇIOĞLU B., et al.
2.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Türkiye, 10 - 11 Mayıs 2018, (Özet Bildiri)

27. Assessment of knowledge and attitude of women utilized oral contraception

KURŞUN H., OKUYAN B., BARRİ R., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

28. Retrospectively Assessment of Acid Supression Therapy in Internal Medicine Service

Ince I., Torun B., Ozdemir B., Belentepe A., Ozkan O., DEMİRTUNÇ R., et al.
International Meeting on EducationResearch in Health Sciences (IMER-HS9, İstanbul, Türkiye, 3 - 05 Kasım 2017, (Özet Bildiri)

29. Evaluation of Internet-based Drug Information Center Conducted by Clinical Pharmacist

İZZETTİN F. V., YILMAZ Z. K., OKUYAN B., SANCAR M.
International Meeting on Education and Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri)

30. Assessment of Patients’ with Hypertension Cardiovascular Disease Risk Knowledge Level at Community Pharmacy Setting

ÖZKAN ÖZDOĞAN F., ÖZKAN Ö., TORUN B., UZUN G. D., SANCAR M., OKUYAN B.
International Meeting on Education and Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

31. Retrospectively Assessment of Acid Suppression Therapy in Internal Medicine Service

İNCE İ., TORUN B., LEBLEBİCİ A., ÖZDEMİR B., BELENTEPE A., ÖZKAN Ö., et al.
International Meeting on Education and Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri)

32. Reliability of the Turkish Version of the Oral Anticoagulation Knowledge (OAK) Test

TÜRKER M., SANCAR M., DEMİRTUNÇ R., UZMAN O., AY N. P., KOZAN Ö., et al.
International Meeting on Education and Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri)

33. Evaluation of Pharmacist’s role related to corticosteroid usage: Corticophobia

İZZETTİN F. V., TEZCAN S., Çakıcı G., ŞAHİN Y., SANCAR M.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

34. Inter-professional training:the importance of clinical rounds in clinical pharmacy education

SANCAR M., İZZETTİN F. V., OKUYAN B.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

35. Medication adherence and medication regimen complexity of patients with polypharmacy setting

LEBLEBİCİ A., TORUN B., ÖZKAN Ö., ÖZDEMİR B., BELENTEPE A., İNCE İ., et al.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

36. The role of clinical pharmacist in evaluation of cardiometabolic risk and drug related problems in patients with bipolar disorder

YANG S., SANCAR M., OKUYAN B., BİNGÖL ÖZAKPINAR Ö., NEBİOĞLU M., ÇALIŞKAN M., et al.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

37. Medication adherence and medication regimen complexity of patients with polypharmacy at community pharmacy setting

LEBLEBİCİ A., TORUN B., ÖZKAN Ö., ÖZDEMİR B., BELENTEPE A., İNCE İ., et al.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

38. Inter-professional Training: The Importance of Clinical Rounds in Clinical Pharmacy

SANCAR M., İZZETTİN F. V., OKUYAN B.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

39. Evaluation of Anthypertensive Medication Adherence at Community Pharmacy Setting

CAKİR N., OKUYAN B., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

40. Potential Drug Interactions with Cigarette Smoking at Community Pharmacy Setting

OZBEY S., GUL DUYGU U., SANCAR M., OKUYAN B.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

41. Assessment of Self-care and Fear of Self-injecting and Self-testing in Diabetic Patients Utilized Insulin

ÖZELÇİ T., ÖZKAN Ö., TORUN B., SANCAR M., OKUYAN B.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

42. Importance of Medication Dose Adjustment in Hospitalized Patients with Impaired Renal Function at Internal Medicine Ward: The Possible Impact of Clinical Pharmacist

ALTAY A., ÖZKAN Ö., DEMİRTUNÇ R., OKUYAN B., İZZETTİN F. V., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, October 2017, 9 - 11 Ekim 2017, (Özet Bildiri)

43. The Evaluation of Parents Attitude Towards Antibiotic Use in Children In the Age of Primary School

AK D., İZZETTİN F. V., OKUYAN B., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

44. Assessment of Individuals’ Cardiovascular Disease Risk Knowledge Levelat Community Pharmacy Setting

ÖZPOLAT S., TORUN B., ÖZKAN Ö., SANCAR M., OKUYAN B.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

45. Attitudes of Visually Disabled People Towards Medication Usage -Primary Research

BELENTEPE A., ÖZKAN Ö., LEBLEBİCİ A., ÖZDEMİR B., İNCE İ., TORUN B., et al.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

46. Evaluation of The Different Patient Education Methods Given By The Clinical Pharmacist

YILMAZ Z. K., SANCAR M., OKUYAN B., YEŞİLDAĞ O., İZZETTİN F. V.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

47. Drug Related Problems Identified by Clinical Pharmacist at the Internal Medicine Ward

ABUNAHLAH N. Y. A., El Awaisi A., Velibeyoğlu F. M., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, 8 - 10 Ekim 2017, (Özet Bildiri)

48. Tüberküloz tedavisi alan çocuk hastalarda yüksek basınçlı sıvı kromatografi yöntemi ile terapötik ilaç izlemi

KARAKUŞ S., SANCAR M., DALGIC N., OKUYAN B., ÇAKIR E., MIDYAT L., et al.
17.Kromatografi Kongresi (Kromatografi 2017), Çorum, Türkiye, 20 - 22 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

49. Hasta izlemi ve klinik uygulama becerileri interaktif atölye çalışması,

İZZETTİN F. V., SANCAR M., RABUŞ Ş., OKUYAN B.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017

50. Cost Analysis of Lactobacillus reuteri DSM 17938 in Children with Acute Infectious Gastroenteritis.

Dinleyici E. C., Ozen M., KARA A., Dalgic N., Kurugol Z., Guven S., et al.
50th Annual Meeting of ESPGHAN, PRAG, Çek Cumhuriyeti, 10 - 13 Mayıs 2017, cilt.64, ss.432-433, (Özet Bildiri)

51. Eczacılıkta Kariyer Alanları oturumunda ”Klinik Eczacılık”

SANCAR M.
3. Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

52. Eczacılık Lisans Eğitimi: Beklentiler ve Öneriler oturumunda ”Neden Klinikte Eğitim?”

SANCAR M.
3. Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

53. Ebeveynlerin ilköğretim çağındaki çocuklarda antibiyotik kullanımı hakkındaki tutumlarının değerlendirilmesi,

AK D., İZZETTİN F. V., SANCAR M., OKUYAN B.
3. İVEK, 26 - 29 Nisan 2017, (Özet Bildiri)

54. probage study:Final report of the largest clinical trial with probiotic/synbiotics in children with acute infectious gastroenteritis in Turkey

DİNLEYİCİ E. Ç., KARA A., ÖZEN M., Dalgıç N., GÜVEN Ş., KURUGÖL N. Z., et al.
50.Annual meeting of ESPGHAN, 10 - 13 Mayıs 2017, (Özet Bildiri)

55. Dahiliye servisine yatan hastalarıkullandıkları ilaçlar arasındaki olası ilaç-ilaç etkileşimleri

ODABAŞI G., OKUYAN B., İZZETTİN F. V., DEMİRTUNÇ R., SANCAR M.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri)

56. Assessment of port catheter complications in cancer patients impact of clinical pharmacist care

Köseoğlu A., Altaie A. H., Aliustaoğlu M., SANCAR M., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

57. Investigation of Medication Profile of Patients During Hospital Admission

ODABAŞI G., OKUYAN B., SANCAR M., İZZETTİN F. V., demirtunç r.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri) identifier

58. The evaluation of elderly patients medication profile at community pharmacy setting

OKUYAN B., atakulu n., ÖZKAN Ö., İZZETTİN F. V., SANCAR M.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri) identifier

59. Determination of medication adherence in hypertensive patients in Turkey and North Cyprus

Zengin D., SANCAR M.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri)

60. Evaluation of rational antibiotic dispending in the community pharmacy setting a simulated patient study

OKUYAN B., Savan M. A., SANCAR M., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri)

61. Impact of Antiemetic guideline consistency on the patient s quality of life

ABUNAHLAH N. Y. A., ALQOZBAKR T. A. B., SANCAR M.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri)

62. Staj ve Öğrenme Hedefleri

UĞURLU T., ŞENER A., KERİMOĞLU O., SANCAR M., KARAKUŞ S., KAYMAKÇIOĞLU B., et al.
I.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 9 - 10 Mayıs 2016, (Özet Bildiri)

63. Eczacılık Eğitiminde Klinik Uygulamaların Önemi Marmara Üniversitesi Örneği

İZZETTİN F. V., SANCAR M., TEZCAN S., ŞAHİN Y., ÖZKAN Ö.
1. ulusal eczacılık eğitimi ve akreditasyon kongresi, Türkiye, 9 - 10 Mayıs 2016, (Özet Bildiri)

64. Marmara Üniversitesi Eczacılık Fakültesi nde Akreditasyon Süreci

Sancar M., Elçioğlu H. K., Küçükgüzel İ., Akbuğa J., Kaymakçıoğlu B., Göktürk S., et al.
I.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, HacettepeÜniversitesi,Ankara, Ankara, Türkiye, 9 - 10 Mayıs 2016, cilt.1, ss.14, (Özet Bildiri) Creative Commons License

65. DETERMINATION OF PHARMACEUTICAL CARE NEEDS IN PATIENTS WITH COLON CANCER AT AN AMBULATORY SETTING

TEZCAN S., İZZETTİN F. V., SANCAR M., YUMUK P. F., TURHAL S.
44TH ESCP SYMPOSIUM, 29 - 31 Ekim 2015, cilt.38, ss.557, (Özet Bildiri) Sürdürülebilir Kalkınma

66. Kanser Hastalarında İlaç Kaynaklı Problemlerin Belirlenmesinde Klinik Onkoloji Eczacısının Rolü

TEZCAN S., SANCAR M., TURHAL S., YUMUK P. F., İZZETTİN F. V.
2. ULUSLARARASI İLAÇ VE ECZACILIK KONGRESİ, 27 - 29 Kasım 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

67. KANSER HASTALARINDA İLAÇ KAYNAKLI PROBLEMLERİN BELİRLENMESİNDE KLİNİK ONKOLOJİ ECZACISININ ROLÜ

TEZCAN S., SANCAR M., TURHAL S., YUMUK P., İZZETTİN F. V.
2. Uluslararası İlaç ve Eczacılık Kongresi, 27 - 29 Kasım 2015 Sürdürülebilir Kalkınma

68. Clinical Based Education in Clinical Pharmacy Graduate Programs

SANCAR M.
International Gazi Pharma Symposium Series, 13 - 15 Kasım 2015, (Özet Bildiri)

69. Determination of Potential Drug Drug Interactions by Using Various Software Programs at Community Pharmacy Setting

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
44th European Symposium on Clinical Pharmacy, LİZBON, Portekiz, 28 - 30 Ekim 2015

70. Pharmaceutical Care Impact on Certain Biochemical Levels in Diabetic Cancer Patients

SANCAR M., kaşık a., BATUHAN S., BABİ B., İZZETTİN F. V., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, 28 - 30 Ekim 2015 Sürdürülebilir Kalkınma

71. Evaluation of Potentially Inappropriate Medication Use and Drug Burden Index in Elderly Patients with Cancer

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
44th European Symposium on Clinical Pharmacy, LİZBON, Portekiz, 28 - 30 Ekim 2015 Sürdürülebilir Kalkınma

72. Determination of Potentially Drug Drug Interaction in Oncology Patients 44th ESCP Symposium on Clinical Pharmacy

SANCAR M., kaşık a., BATUHAN S., BABİ B., İZZETTİN F. V., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, 28 - 30 Ekim 2015

73. Assessment of Attitude and Knowledge in Patients Utilized Disposable Insulin Pens at Community Pharmacy Setting

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
44th European Symposium on Clinical Pharmacy, LİZBON, Portekiz, 28 - 30 Ekim 2015

74. Determination of Pharmaceutical Care Needs in Patients with Colon Cancar at An Ambulatory Setting

SANCAR M., kaşık a., BATUHAN S., BABİ B., İZZETTİN F. V., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, 28 - 30 Ekim 2015

75. Determination of Potential Drug Drug Interactions by Using Various Drug Interaction Software Programs at Hospital Pharmacy Setting

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
44th European Symposium on Clinical Pharmacy, LİZBON, Portekiz, 28 - 30 Ekim 2015

76. Implementation of Medication Reconciliation and Medication Review Services Conducted by Pharmacist in Hospitalized COPD Patients

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
44th European Symposium on Clinical Pharmacy, LİZBON, Portekiz, 28 - 30 Ekim 2015

77. Drug Drug Interaction in Patients Using Proton Pump Inhibitors A Patient Drug Profile Study

SANCAR M., kaşık a., BATUHAN S., BABİ B., İZZETTİN F. V., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, 28 - 30 Ekim 2015, (Özet Bildiri)

78. Clinical pharmacy services in community pharmacy

SANCAR M.
INTERNATIONAL MULTIDISCIPLINARY SYMPOSIUM ON DRUG RESEARCH & DEVELOPMENT, 15 - 17 Ekim 2015, (Özet Bildiri)

79. wound healing activityof Cotinus coggygrus in diabetic rats

AKSOY H., ŞEN A., SANCAR M., AKAKIN D., BİTİŞ L., URAS F., et al.
11th international symposium pharmaceutical sciences ankara 2015, Türkiye, 9 - 12 Haziran 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

80. Wound healing activity of Cotinus coggygria in diabetic rats

AKSOY H. Z., ŞEN A., SANCAR M., AKAKIN D., BİTİŞ L., URAS F., et al.
11th International Symposium on Pharmaceutical Sciences (ISOPS-11), Ankara, Türkiye, 9 - 12 Haziran 2015, ss.359-360, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

81. Hasta Odaklı Eczacılık Uygulamaları

SANCAR M.
2. İstanbul Eczacılık Kongresi, Türkiye, 22 - 24 Mayıs 2015

82. Klinik Eczacılık Uzmanlığı

SANCAR M.
Yarışmalı Eczacılık Mezuniyet Projeleri Sempozyumu, Türkiye, 15 - 17 Mayıs 2015

83. Nefrolojide Eczacının Rolü

SANCAR M.
Ulusal Hastane ve Kamu Eczacıları Kongresi, Türkiye, 02 Nisan 2014 - 06 Nisan 2015

84. Akılcı İlaç Kullanımı ve Türkiye deki Durum

SANCAR M.
3. Şişli Etfal Çocuk Dostları Kongresi, Türkiye, 2 - 04 Nisan 2015

85. Yatan Hastalarda İlaç Uzlaşısı

SANCAR M.
TEB Kamu Eczacıları Kongresi, Türkiye, 6 - 07 Mart 2015

86. Evaluation of drug burden index and medication utilization in geriatric patients at community pharmacy

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.206-207

87. Evaluation of drug burden index in elderly patients utilized disposable insulin pen

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.203-204

88. Assessment of patients knowledge and attitude towards methotrexate utilization

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.256

89. Assessment of knowledge and attitude towards osteoporosis among women attending community pharmacy settings

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.213 Sürdürülebilir Kalkınma

90. Implementation of medication reconciliation and medication review services conducted by pharmacist in hospitalized elderly patients

SANCAR M., GİRGİN I., SELÇUK A., YANG S., İZZETTİN F. V., OKUYAN B.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014, cilt.37

91. Evaluation of drug burden index in elderly patients utilized inhaler

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.205

92. The role of pharmacist in detecting angiotensin converting enzyme inhibitors induced dry cough at community pharmacy setting

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.207

93. Determination of drug related problem and drug burden index in elderly patients

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
43rd European Symposium on Clinical Pharmacy, KOPENHANG, Danimarka, 22 - 24 Ekim 2014, cilt.37, ss.208-209

94. Protective Effects of Tempol and Silymarin Against Cisplatin Induced Hepatotoxicity In Rats

ALGOZBAKIR T., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., OKUYAN B., ŞEKERLER T., KOLBAŞI B., et al.
Uluslararası İlaç ve Eczacılık Kongresi (İVEK), 28 - 30 Kasım 2014

95. Bipolar Bozukluk Tanısı Almış Hastalarda Kardiyometabolik Risklerin ve İlaç Kaynaklı Problemlerin Saptanması

YANG S., OKUYAN B., BİNGÖL ÖZAKPINAR Ö., NEBİOĞLU M., ÇALIŞKAN M., ÇIRAKLI Z., et al.
Uluslararası İlaç ve Eczacılık Kongresi (İVEK), 28 - 30 Kasım 2014

96. Hasta Bazlı İlaç Uygulamaları

SANCAR M.
V. Uluslararası Sağlıkta Performans ve Kalite Kongresi, 21 - 23 Kasım 2014

97. Bipolar bozukluk tanısı almış hastalarda Kardiyometabolik risklerin ve ilaç kaynaklı problemlerin saptanması

ALQOZBAKR T., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., OKUYAN B., ŞEKERLER T., KOLBAŞI B., et al.
International Congress of Pharmaceuticals and Pharmacies, 28 - 30 Ekim 2014

98. Eczanede Sıkça Rastlanan Semptomlara Yaklaşım

SANCAR M.
12. Türkiye Eczacılık Kongresi, Türkiye, 23 - 26 Ekim 2014

99. The challenge of competent pharmacists in individualized pharmaceutical care plan

OKUYAN B., SANCAR M., İZZETTİN F. V.
43rd ESCP Symposium on Clinical Pharmacy, 22 - 24 Ekim 2014

100. Therapetic Drug Monitoring in Pediatric Patients Treated With Anti-tuberculosis Medications: Preliminary Study

OKUYAN B., SANCAR M., DALGIC N., KARAKUŞ S., ÇAKIR E., MIDYAT L., et al.
(IMPPS-4) FOURTH INTERNATIONAL MEETING ON PHARMACY PHARMACEUTICAL SCIENCES, İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri) Sürdürülebilir Kalkınma

101. Protective effects of ferulic acid and curcumin against cisplatin induced nephrotoxicity in rats

BAMİ E., OKUYAN B., BİNGÖL ÖZAKPINAR Ö., ÖZDEMİR KUMRAL Z. N., KÖROĞLU K., ERCAN F., et al.
Four International Meeting on Pharmacy and Pharmaceutical Sciences (IMPPS-4), 18 - 21 Eylül 2014

102. Protective effects of ferulic acid and curcumin against testicular oxidative damage induced by cisplatin in rats

BAMİ E., OKUYAN B., BİNGÖL ÖZAKPINAR Ö., ÖZDEMİR KUMRAL Z. N., KÖROĞLU K., ERCAN F., et al.
Four International Meeting on Pharmacy and Pharmaceutical Sciences (IMPPS-4)., 18 - 21 Eylül 2014

103. Protective effects of ferulic acide and curcumin against cisplatin induced nephrotoxicity in rats

SANCAR M., GİRGİN I., SELÇUK A., YANG S., İZZETTİN F. V., OKUYAN B.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014

104. Protective effects of ferulic acide and curcumin against testicular oxidative damage induced by cisplatin in rats

SANCAR M., GİRGİN I., SELÇUK A., YANG S., İZZETTİN F. V., OKUYAN B.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014

105. Determination of CYP2C19 polymorphisms adverse drug reaction and medication adherence in patients utilized selective serotonin reuptake inhibitors

DENİZ S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., TALAS A., et al.
Four International Meeting on Pharmacy and Pharmaceutical Sciences (IMPPS-4), 18 - 21 Eylül 2014

106. Determınantıon of medication utilization and illness perception among patients with II diabates mellitus

SANCAR M., GİRGİN I., SELÇUK A., YANG S., İZZETTİN F. V., OKUYAN B.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014

107. Illness perception and diabetes self care activities in patients with type II diabetes mellitus at community pharmacy setting

DOĞRUSEVER H., OKUYAN B., SANCAR M., ELÇİOĞLU H. K.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014 Sürdürülebilir Kalkınma

108. Determinantion of medication utilization and illness perception among patients with II diabates mellitus

ELÇİOĞLU H. K., ÇAĞLAYAN B., DEMİREL A. Ç., DEYNELİ O., SANCAR M., OKUYAN B.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014

109. Therapeutic drug monitoring in pediatric patients treated with anti tuberculosis medications preliminary study

OKUYAN B., SANCAR M., DALGIÇ N., KARAKUŞ S., ÇAKIR E., MİDYAT L., et al.
Fourth International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014 Sürdürülebilir Kalkınma

110. Güncel Farmakoterapi Yeni Diyabet İlaçlarının Klinik Kullanımı

SANCAR M., OKUYAN B.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013 Sürdürülebilir Kalkınma

111. Kadınların Menopozla ilişkili Farmasötik Bakım İhtiyaçlarının Değerlendirilmesi

ELMAS L., İZZETTİN F. V., OKUYAN B., SANCAR M.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013

112. Glukozamin ve Kondroitin Kullanan Bireylerin Tutum ve Bilgilerinin Değerlendirilmesi

OKUYAN B., SOYUGÜZEL G., İZZETTİN F. V., ALQOZBAKR T., SANCAR M.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013

113. Serbest Eczanede Diyabet Hastalarının Ayak Bakımı ile İlgili Tutumlarının Değerlendirilmesi

SANCAR M., SUKUZU H., AKYILDIZ M., OKUYAN B., DENİZ S., İZZETTİN F. V.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013 Sürdürülebilir Kalkınma

114. Kadınların Menopoza Karşı Tutumlarının Belirlenmesi

SANCAR M., YETİM A., DURMAZ E. Ö., OKUYAN B., ALQOZBAKR T., İZZETTİN F. V.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013

115. Majör Depresyon Hastalarında İlaç Profilinin ve Hasta Uyuncunun Tespit Edilmesi

SANCAR M., DÜZGÜN E., OKUYAN B., DENİZ S., ÇALIŞKAN M., COŞKUN K., et al.
2. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 28 Kasım - 01 Aralık 2013

116. Assessment of Knowledge Attitude and Quality of Life in Patients Utilized Topical Corticosteroid

OKUYAN B., GÜNDÜZ B., DENİZ S., ŞAHİNER S., SANCAR M., İZZETTİN F. V.
42nd European Symposium on Clinical Pharmacy: Implementation of Clinical Pharmacy Practice, 16 - 18 Ekim 2013, cilt.35

117. The Determination of Knowledge and Attitude of Women toward Oral Contraceptive Pills

OKUYAN B., YILMAZ M., DENİZ S., ÖZDEMİR A. H., SANCAR M., İZZETTİN F. V.
42nd European Symposium on Clinical Pharmacy: Implementation of Clinical Pharmacy Practice, 16 - 18 Ekim 2013, cilt.35 Sürdürülebilir Kalkınma

118. Attitude and Knowledge of Hospitalized Patients with Type 2 Diabetes Mellitus Towards Disposable Insulin Pens Utilization

OKUYAN B., SAĞLAM B., EMRE E., KARATAŞ KOÇBERBER E., HÜCUM H., DEMİRTUNÇ R., et al.
42nd European Symposium on Clinical Pharmacy: Implementation of Clinical Pharmacy Practice, 16 - 18 Ekim 2013, cilt.35 Sürdürülebilir Kalkınma

119. The Determination of Knowledge and Attitude toward Contraception of Women Utilized Isotretinoin preliminary study

OKUYAN B., ÖZDEMİR A. H., DENİZ S., YILMAZ M., SANCAR M., İZZETTİN F. V.
42nd European Symposium on Clinical Pharmacy: Implementation of Clinical Pharmacy Practice, 16 - 18 Ekim 2013, cilt.35 Sürdürülebilir Kalkınma

120. The Effects Of Cotinus Coggygrıascop Ethanol Extract On Cutaneous Wound Healıng In Rats

AKSOY H. Z., ŞEN A., SANCAR M., OKUYAN B., BİTİŞ L., URAS F., et al.
The 17th International Congress Phytopharm 2013, 8 - 10 Temmuz 2013

121. The effects of Cotinus coggygria Scop. ethanol extract on cutaneous wound healing in rats

AKSOY H., ŞEN A., SANCAR M., OKUYAN B., BİTİŞ L., URAS F., et al.
Phytopharm2013, 8 - 10 Temmuz 2013, (Özet Bildiri)

122. The assessment of self-medication utilization in pain management at a community pharmacy setting

OKUYAN B., Atalay M. V., Sahin C., Sahin D., Izzettin F. V., SANCAR M.
Symposium of the American-College-of-Clinical-Pharmacy, ELECTR NETWORK, 21 - 22 Mayıs 2013, cilt.33, (Özet Bildiri) identifier

123. Assessment of medication knowledge among geriatric patients at a community pharmacy setting

OKUYAN B., Duzgun U., Arslan H. I., Sap S., Girgin I., Elmas L., et al.
Symposium of the American-College-of-Clinical-Pharmacy, ELECTR NETWORK, 21 - 22 Mayıs 2013, cilt.33, (Özet Bildiri) identifier

124. Attitude and use of herbal remedies among pregnant women

KONYALI T., SANCAR M., SARICA P., TEZCAN S., YEŞİLYURT M., İZZETTİN F. V.
41st ESCP Symposium on Clinical Pharmacy, 29 - 31 Ekim 2012, (Özet Bildiri) Sürdürülebilir Kalkınma

125. Evaluation of medication utilization skill in geriatric patents a community pharmacy setting

OKUYAN B., ASLAN İ. H., SAP S., SANCAR M., DÜZGÜN Ü. Z., GİRGİN İ., et al.
41st European Symposium on Clinical Pharmacy: Personalised and Safe Therapy, 29 - 31 Ekim 2012, cilt.35

126. The Self Care Activities of Diabetic Patients at Community Pharmacy Setting Introduction to Pharmaceutical Care

OKUYAN B., ÖCAL Y., SANCAR M., DENİZ S., DAYAN A., DEMİRTUNÇ R., et al.
41st European Symposium on Clinical Pharmacy: Personalised and Safe Therapy, 29 - 31 Ekim 2012, cilt.35 Sürdürülebilir Kalkınma

127. The Adverse Drug Reaction Reporting Center A Community Pharmacy

OKUYAN B., ŞAHİN D., SANCAR M., ŞAHİN C., ATALAY M. V., İZZETTİN F. V.
41st European Symposium on Clinical Pharmacy: Personalised and Safe Therapy, 29 - 31 Ekim 2012, cilt.35

128. The Implementation of Pharmacist Driven Medication Reconciliation Program at the Admission to Hospital

SANCAR M., ER E., TURAN B., OZKER P., İZZETTİN F. V., OKUYAN B.
41st European Symposium on Clinical Pharmacy: Personalised and Safe Therapy, 29 - 31 Ekim 2012, cilt.35

129. The Evaluation of Pharmacy Students Perception Toward Patient Oriented Pharmacy Services

SANCAR M., BEŞKARDEŞLER N., OKUYAN B., İZZETTİN F. V.
41st European Symposium on Clinical Pharmacy: Personalised and Safe Therapy, 29 - 31 Ekim 2012, cilt.35

130. Turkısh community pharmacists and pharmacy technicians attitude towards diarrhea cases a simulated patient study

SANCAR M., TEZCAN E., OKUYAN B., İZZETTİN F. V.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2012 Sürdürülebilir Kalkınma

131. Osteoporosıs risk screening program at community pharmacy

OKUYAN B., SANCAR M., DEMIREL N. S., YORUKOGLU E., KORKMAZ HAVSA T., SOYDEGER CARLI B., et al.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2012

132. The assessment of drug profile and measurement of medication adherence in patients with hypertension

OKUYAN B., SANCAR M., TUNCKOL G., POLAT E., İZZETTİN F. V.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2012

133. Doktorların Eczacıların Başlıca Görevleri Hakkındaki Görüşleri ve Mesleki İşbirliğine Bakışlarının Değerlendirilmesi

GÜNEŞ L., SANCAR M., OKUYAN B., İZZETTİN F. V.
1st International Pharmacy Graduation Projects Symposium, Türkiye, 15 - 16 Haziran 2012

134. Sıçanlarda Çeşitli Kemoterapi Rejimlerinin Hepatotoksisitesi Üzerine Atorvastatin ve Ginkgo Biloba nın Etkileri

OKUYAN B., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., TURAN P., ÖZDEMİR KUMRAL Z. N., SANCAR M., et al.
XXIII. Ulusal Biyokimya Kongresi, Türkiye, 29 Kasım - 02 Aralık 2011, cilt.36

135. Assessment of pharmacy technicians attitudes and responsibilities toward patient oriented pharmacy practices at community pharmacy

SANCAR M., OKUYAN B., TAMYÜKSEL E., İZZETTİN F. V.
40th ESCP Symposium on Clinical Pharmacy: Connecting Care & Outcomes, 19 - 21 Ekim 2011, cilt.34

136. Levofloksasinin İnsan Nötrofil Fonksiyonlari Üzerine Etkisinin İn Vitro Değerlendirilmesi

CÖMERTER H., KADİR T., OKUYAN B., SANCAR M., İZZETTİN F. V.
26. ANKEM Antibiyotik ve Kemoterapi Kongresi, Türkiye, 18 - 22 Mayıs 2011

137. Serbest Eczanede Diyabet Hastalarının İlaç Profillerinin ve Farmasötik Bakım İhtiyaçlarının Saptanması

ÖZKAN F., İLHAN A. E., ESER Ç., OKUYAN B., SANCAR M.
2. MEFKO Kongresi, Türkiye, 6 - 08 Mayıs 2011 Sürdürülebilir Kalkınma

138. Effect of addition of montelukast to the asthma maintenance treatment on the clinical and humanistic outcomes

YILDIRIM E., RABUŞ Ş., Yildiz P., SANCAR M., ANIL B., İZZETTİN F. V.
Proceedings: 39th European Symposium on Clinical Pharmacy Lyon, France, 21-23 October 2010., Lyon, Fransa, 21 - 23 Ekim 2010, (Özet Bildiri)

139. How much do the faculty courses contribute to daily pharmacy practice

RABUŞ Ş., SANCAR M., İZZETTİN F. V.
Proceedings: 39th European Symposium on Clinical Pharmacy Lyon, France, 21-23 October 2010., Lyon, Fransa, 21 - 23 Ekim 2010, (Özet Bildiri)

140. Characteristics of the drug disease information service demanded from the community pharmacist

RABUŞ Ş., PAKALPAKCİL O., OKUYAN B., SANCAR M., SOYDEGER CARLI B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33

141. Determination of knowledge and attitude of self care among patients with hypertension

OKUYAN B., GÜLEŞ M., SANCAR M., RABUŞ Ş., SOYDEĞER CARLI B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33

142. Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting

SANCAR M., AKYILDIZ E., OKUYAN B., RABUŞ Ş., SOYDEĞER CARLI B., YILMAZ Z., et al.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33 Sürdürülebilir Kalkınma

143. Determination of knowledge and pharmaceutical care ıssues in senile osteoporotic women

YORUKOGLU E., ŞAHİN Z., SANCAR M., OKUYAN B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33 Sürdürülebilir Kalkınma

144. Identification potential drug drug interaction in elderly patients receiving polypharmacy prescription

SANCAR M., DOGANYILDIZ P., OKUYAN B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33

145. Outcomes of diabetes risk testing performed at community pharmacy setting

RABUŞ Ş., TURE Z., SANCAR M., OKUYAN B., SOYDEGER CARLI B., YILMAZ Z., et al.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33 Sürdürülebilir Kalkınma

146. Dicle Üniversitesi Tıp Fakültesi Hastanesi nde tedavi gören diyabet hastalarının farmasötik bakım ihtiyaçlarının belirlenmesi

ÇİÇEK M., SANCAR M., RABUŞ Ş., OKUYAN B., GÖKALP D., İZZETTİN F. V.
10. Türkiye Eczacılık Kongresi, Türkiye, 30 Eylül - 03 Ekim 2010 Sürdürülebilir Kalkınma

147. Anjiyotensin dönüştürücü enzim inhibitörleri hakkında eczacının bilmesi gerekenler klinik kullanımları ve farklılıkları

YILMAZ Z., SANCAR M., OKUYAN B., İZZETTİN F. V.
10. Türkiye Eczacılık Kongresi, Türkiye, 30 Eylül - 03 Ekim 2010

148. Assessment of the 5th grade pharmacy students opinions on the first time held pharmacy practice I course of the second cycle

SOYDEĞER CARLI B., OKUYAN B., RABUŞ Ş., SANCAR M., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010

149. The biochemical assessment of the effectsof Nigella sativa oil on cutaneous wound healing in rats

AKSOY H. Z., RABUŞ Ş., SANCAR M., OKUYAN B., URAS F., İZZETTİN F. V.
Third International Meeting on Pharmacy and Pharmaceutical Sciences Istanbul Turkey 2010, 09 Haziran 2010, (Özet Bildiri)

150. Evaluation of dietary supplement consumption at community pharmacy setting

OKUYAN B., KAYA E., SANCAR M., RABUŞ Ş., SOYDEĞER CARLI B., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010

151. Turkish certified pharmacy technicians counseling practices and attitudes regarding emergency contraceptive pills

RABUŞ Ş., SANCAR M., OKUYAN B., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010

152. Workshop on pharmaceutical care in diabetes

İZZETTİN F. V., SANCAR M., RABUŞ Ş., OKUYAN B.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010 Sürdürülebilir Kalkınma

153. The biochemical assessment of the effects of Nigella sativa oil on cutaneous wound healing in rats

AKSOY H., RABUŞ Ş., SANCAR M., OKUYAN B., URAS F., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010

154. Monitoring of theophylline levels in patients with acute exacerbation of chronic obstructive pulmonary disease

SOYDEĞER CARLI B., İZZETTİN F. V., OKUYAN B., SANCAR M., KARAGÖZ T.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010

155. A Patient Drug Profile Study in Acute Myocardial Infarction

ERZEN T., SANCAR M., OKUYAN B., İZZETTİN F. V.
ESCP-GSASA 38th Symposium on Clinical Pharmacy, 3 - 06 Kasım 2009, cilt.32 identifier

156. Medication Use Evaluation During Acute Exacerbation and Stable Periods in Patients with Chronic Obstructive Pulmonary Disease

SOYDEĞER B., SANCAR M., OKUYAN B., CARLI Ö., KARAGÖZ T., İZZETTİN F. V.
ESCP-GSASA 38th Symposium on Clinical Pharmacy, 3 - 06 Kasım 2009, cilt.32

157. Clinical Pharmacy Workshop and Patient Centred Teaching

İZZETTİN F. V., DEMİRKAN S. K., SANCAR M., RABUŞ Ş.
9th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 23 - 26 Haziran 2009, (Tam Metin Bildiri)

158. Assessment of a Clinical Pharmacy Continuing Education Program in Turkey

SANCAR M., OKUYAN B., RABUŞ Ş., SOYDEĞER B., İZZETTİN F. V.
9th International Symposium on Pharmaceutical Sciences, 23 - 26 Haziran 2009

159. Effects of topical verapamil administration on acute tympanic membrane perforation in guinea pigs

EKEN M., İZZETTİN F. V., EKEN M., SANCAR M., OKUYAN B.
ACCP/ESCP International Congress on Clinical Pharmacy, 24 - 28 Nisan 2009, cilt.29

160. Protective effects of Nigella sativa oil on antituberculous drug combination induced hepatotoxicity in rats

ŞENER N., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., RABUŞ M. B., OKUYAN B., SANCAR M., et al.
ACCP/ESCP International Congress on Clinical Pharmacy, 24 - 28 Nisan 2009, cilt.29

161. An evaluation of systemic and topical treatments of otitis media a hospital study in Turkey

EKEN M., OKUYAN B., SANCAR M., EKEN M., İZZETTİN F. V.
36th European Symposium on Clinical Pharmacy: Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience, 25 - 27 Ekim 2007, cilt.30, ss.649-740

162. Yaşam Kalitesinin Değerlendirilmesinde Klinik Eczacının Rolü

EMİNZADE S., SANCAR M., OKUYAN B., İZZETTİN F. V.
İstanbul Eczacılık Kongresi, Türkiye, 8 - 10 Aralık 2006

163. Antibiyotik Kullanımında Klinik Eczacının Rolleri ve Antibiyotiklerin İmmün Sistem Üzerine Etkileri

OKUYAN B., SANCAR M., İZZETTİN F. V.
8. Türkiye Eczacılık Kongresi, Türkiye, 26 - 29 Ekim 2006

164. Comparison of the effect of Glycyrrhiza glabra with different antiulcer drugs on aspirin induced ulcer in rats

HANTASH T., SANCAR M., OKUYAN B., ÇIRAKLI Z., ÇEVİKBAŞ U., URAS F., et al.
8th International Symposium on Pharmaceutical Sciences, 13 - 16 Haziran 2006

165. Mid-term results of secondary prevention in coronary artery disease: drug utilization profiles.

RABUŞ Ş., İZZETTİN F. V., SANCAR M., Karakaya O., Kargin R., Yakut C.
Proceedings: 6th ESCP Spring Conference - Chronic Disease Management: the Role of the Pharmacist, Vilniaus, Litvanya, 25 - 27 Mayıs 2006, (Özet Bildiri)

166. Community pharmacists opinion on pharmaceutical care practice in Turkey

SANCAR M., OKUYAN B., RABUŞ Ş., İZZETTİN F. V.
7th ESCP Spring Conference: Tackling Inequalities in the Delivery of Pharmaceutical Care, 16 - 19 Mayıs 2007, cilt.31, ss.40-141

167. Cardiovascular Drug Prescription in Type 2 Diabetes

İZZETTİN F. V., RABUŞ Ş., SANCAR M., Gebologlu N., Hursitoglu M.
34th European Symposium on Clinical Pharmacy, Amsterdam, Hollanda, 26 - 29 Ekim 2005, ss.513, (Özet Bildiri) Sürdürülebilir Kalkınma

168. Tüberküloz Hastalarına Uygulanan Doğrudan Gözetim Tedavisinde Eczacının Rolü

OKUYAN B., CLARK P., AZARMİR S., SANCAR M., İZZETTİN F. V.
I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, Türkiye, 23 - 25 Eylül 2005 Sürdürülebilir Kalkınma

169. Prescription profiles in primary and secondary coronary artery disease prevention

RABUŞ Ş., SANCAR M., Eskisar A., Turan F., Yakut C., İZZETTİN F. V.
33rd European Symposium on Clinical Pharmacy, Prague, Çek Cumhuriyeti, 20 - 23 Ekim 2004, ss.103, (Özet Bildiri)

170. Outcomes of pharmaceutical care in type 2 diabetes patient education and monitoring

Turnacilar M., SANCAR M., RABUŞ Ş., Izzettin N., Turnacilar E., İZZETTİN F. V.
33rd European Symposium on Clinical Pharmacy, Prague, Çek Cumhuriyeti, 20 - 23 Ekim 2004, ss.13, (Özet Bildiri) Sürdürülebilir Kalkınma

171. An in vitro investigation of the effect of antituberculous drugs on functions of polymorphonuclear leukocyte

OKUYAN B., İZZETTİN F. V., ÇEVİKBAŞ A., SANCAR M., SOYOĞUL GÜRER Ü.
33rd European Symposium on Clinical Pharmacy: Risk Management in Pharmacotherapy, 20 - 23 Ekim 2004, cilt.27

172. Improvement of pharmacists knowledge with continuing education programs

DEMİRKAN S. K., Yılmaz D., SANCAR M., İZZETTİN F. V., RABUŞ Ş.
2nd Joint Meeting ESCP-ACCP, Paris, Fransa, 28 - 30 Nisan 2004, ss.13, (Özet Bildiri)

173. ”Pharmacist’s role in management of upper respiratory tract infections” Üst solunum yolları enfeksiyonlarının tedavisinde eczacının rolü

İZZETTİN F. V., SANCAR M., RABUŞ Ş.
International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 27 Haziran 2003
Kitaplar 10

1. Bulaşıcı Olmayan Hastalıklarla Mücadele – Eczcaıların Katkısı

SANCAR M.
TEB yayınları, 2019

2. Sağlıkta Kalite Standartları ADSH (Ağız ve Diş Sağlığı Hizmetleri)

BESLER A., ESATOĞLU A. E., VARIR A., YILDIZ A. N., KAPLAN A., ŞAHİN A. K., et al.
Anıl Reklam Matbaa Ltd, Şti, Ankara, Ankara, 2017

3. T C MARMARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ EĞİTİM ÖĞRETİM REHBERİ 2016

KÜÇÜKGÜZEL Ş. G., RAYAMAN P., KAYMAKÇIOĞLU B., AKGÜN S. G., SANCAR M., TOK F., et al.
MARMARA ÜNİVERSİTESİ YAYINEVİ, İstanbul, 2016

4. Eczacılık Fakültesi Eğitim Öğretim Rehberi

KÜÇÜKGÜZEL Ş. G., KAYMAKÇIOĞLU B., SANCAR M., UĞURLU T., RAYAMAN P., AKGÜN S. G., et al.
Marmara Üniversitesi Yayınevi, 2016

5. Eczacılık Fakültesi Eğitim Öğretim Rehberi 2016

KÜÇÜKGÜZEL Ş. G., KAYMAKÇIOĞLU B., SANCAR M., UĞURLU T., RAYAMAN P., AKGÜN S. G., et al.
MARMARA ÜNİVERSİTESİ YAYINEVİ, İstanbul, 2016

6. Marmara Üniversitesi Eczacılık Fakültesi Eğitim Öğretim Rehberi 2016

KÜÇÜKGÜZEL Ş. G., KAYMAKÇIOĞLU B., UĞURLU T., SANCAR M., RAYAMAN P., TOK F., et al.
Marmara Üniversitesi Yayınevi, İstanbul, 2016

7. Eczacılık Fakültesi Eğitim Öğretim Rehberi 2016

KÜÇÜKGÜZEL Ş. G., KAYMAKÇIOĞLU B., UĞURLU T., SANCAR M., RAYAMAN P., AKGÜN S. G., et al.
MARMARA ÜNİVERSİTESİ YAYINEVİ, İstanbul, 2016

8. Marmara Üniversitesi Eczacılık Fakültesinin 50. Yılı

Omurtag G. Z., Dölen E., Sancar M., Elçioğlu H. K., Erdoğan G., Kocacık T.
Marmara Üniversitesi Yayınevi, İstanbul, 2013 Creative Commons License

9. İlaç Güvenliği

İZZETTİN F. V., RABUŞ Ş., OKUYAN B., SANCAR M.
Hastane Yönetimi, Haydar Sur, Tunçay Palteki, Editör, Nobel Tıp Kitabevleri, ss.561-576, 2013

10. Gargara Yapma Becerisi

İZZETTİN F. V., SANCAR M.
İlaç Uygulama Becerisi, Prof. Dr. Cengiz Yakıncı, Prof. Dr. Erdem Yeşilada, Editör, TürK Eczacıları Birliği Eczacılı Akademisi, ss.38-39, 2013
Metrikler

Yayın

365

Yayın (WoS)

130

Yayın (Scopus)

113

Atıf (WoS)

605

H-İndeks (WoS)

12

Atıf (Scopus)

792

H-İndeks (Scopus)

16

Atıf (Scholar)

353

H-İndeks (Scholar)

9

Atıf (TrDizin)

11

H-İndeks (TrDizin)

1

Atıf (Sobiad)

9

H-İndeks (Sobiad)

2

Atıf (Diğer Toplam)

24

Tez Danışmanlığı

19

Açık Erişim

23
BM Sürdürülebilir Kalkınma Amaçları